Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Mitotane Tablets

Approval Number

国药准字HJ20230105

CompanyHRA Pharma Rare Diseases SAS

Registration Date

September 5, 2023

Drug Information

Generic Name

米托坦片

Dosage Form

片剂

Strength

0.5g

Drug Type

化学药品

Registration Date

September 5, 2023

Expiry Date

September 4, 2028

Company Information

Applicant Company

Company NameHRA Pharma Rare Diseases SAS

Company Address

200 avenue de Paris, 92320 Chatillon, France

Manufacturing Company

Company NameLATINA PHARMA SPA

Company Address

Via Murillo No. 7 04013-Sermoneta (Latina), Italy

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy